{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:34:09Z","timestamp":1790555649706,"version":"4.1.0"},"reference-count":49,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Preeclampsia (PE) constitutes one of the principal reasons for maternal and perinatal morbidity and mortality worldwide. The circumstance typically implicates formerly healthful normotensive women, after 20 weeks of gestation, typically withinside the third trimester, without regarded threat elements or past deliveries. PE can be further complicated with hemolysis and thrombocytopenia, leading to the emergence of HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low platelets). Both conditions are classified as hypertensive diseases of pregnancy (HDP), and their pathogenesis has been linked to an excessive maternal inflammatory response, accompanied by enhanced endothelial activation. Several studies have found that in pregnancies affected by PE\/HELLP, von Willebrand factor (vWF) antigen levels (vWF:Ag) are significantly elevated, while its cleaving protease (ADAMTS-13, A Disintegrin-like and Metalloprotease with Thrombospondin type 1 motif, member 13) activity is normal to decreased. Furthermore, the higher urine excretion of the terminal complement complex C5b-9, as well as its greater deposition in the placental surface in preeclamptic women, imply that the utero-placental unit\u2019s distinctive deficits are intimately tied to disproportionate complement activation. The goal of this updated evaluation is to provide the most up-to-date molecular advances in the pathophysiology of PE\/HELLP syndromes. Recent medical data on vWF:Ag levels in patients with PE, ADAMTS-13, and dysregulation of the complement system, are highlighted and evaluated. Furthermore, we discuss the relationship between those entities and the progression of the disease, as well as their significance in the diagnostic process. Finally, considering the difficulties in analyzing and controlling those symptoms in pregnant women, we can provide a current diagnostic and therapeutic algorithm.<\/jats:p>","DOI":"10.3390\/ijms23073851","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:34:29Z","timestamp":1648762469000},"page":"3851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Molecular Advances in Preeclampsia and HELLP Syndrome"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-2557","authenticated-orcid":false,"given":"Angeliki","family":"Gardikioti","sequence":"first","affiliation":[{"name":"Hematological Laboratory, Second Department of Internal Medicine, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora-Maria","family":"Venou","sequence":"additional","affiliation":[{"name":"Hematological Laboratory, Second Department of Internal Medicine, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-8208","authenticated-orcid":false,"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[{"name":"Hematology & BMT Unit, General Hospital \u201cGeorge Papanicolaou\u201d, 57010 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9217-4109","authenticated-orcid":false,"given":"Evangelia","family":"Vetsiou","sequence":"additional","affiliation":[{"name":"Hematological Laboratory, Second Department of Internal Medicine, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioulia","family":"Mavrikou","sequence":"additional","affiliation":[{"name":"Hematology & BMT Unit, General Hospital \u201cGeorge Papanicolaou\u201d, 57010 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dinas","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gyneacology, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Daniilidis","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gyneacology, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Vlachaki","sequence":"additional","affiliation":[{"name":"Hematological Laboratory, Second Department of Internal Medicine, Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The Global Impact of Pre-Eclampsia and Eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/1607845412Y.0000000070","article-title":"Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia","volume":"18","author":"Aref","year":"2013","journal-title":"Hematology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","article-title":"The complement system and adverse pregnancy outcomes","volume":"67","author":"Regal","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S1059","DOI":"10.1016\/j.ajog.2020.09.038","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"226","author":"Burwick","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.emc.2019.01.008","article-title":"Hypertensive Disorders of Pregnancy","volume":"37","author":"Wilkerson","year":"2019","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00418-020-01892-8","article-title":"AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia","volume":"154","author":"Fantone","year":"2020","journal-title":"Histochem. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Opichka, M.A., Rappelt, M.W., Gutterman, D.D., Grobe, J.L., and McIntosh, J.J. (2021). Vascular Dysfunction in Preeclampsia. Cells, 10.","DOI":"10.3390\/cells10113055"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5152\/jtgga.2014.14206","article-title":"A new biological marker candidate in female reproductive system diseases: Matrix metalloproteinase with thrombospondin motifs (ADAMTS)","volume":"15","author":"Demircan","year":"2014","journal-title":"J. Turk. Gynecol. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2012.09.026","article-title":"Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): A review","volume":"166","author":"Abildgaard","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MOH.0000000000000169","article-title":"ADAMTS13 and von Willebrand factor interactions","volume":"22","author":"Zander","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-2007-1000365","article-title":"Reduced von Willebrand Factor-Cleaving Protease Levels in Secondary Thrombotic Microangiopathies and Other Diseases","volume":"33","author":"Franchini","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-017-0784-4","article-title":"The Complement System and Preeclampsia","volume":"19","author":"Regal","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10641955.2017.1397690","article-title":"ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia","volume":"37","author":"Kalem","year":"2017","journal-title":"Hypertens. Pregnancy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/ATVBAHA.111.223610","article-title":"Von Willebrand Factor and ADAMTS13","volume":"31","author":"Stepanian","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.cca.2011.07.030","article-title":"ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia","volume":"412","author":"Alpoim","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2016.03.014","article-title":"Are there any additional mechanisms for haemolysis in HELLP syndrome?","volume":"142","author":"Sabau","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/ATVBAHA.117.309735","article-title":"Expression of ADAMTS13 in Normal and Abnormal Placentae and Its Potential Role in Angiogenesis and Placenta Development","volume":"37","author":"Xiao","year":"2017","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2006.02205.x","article-title":"Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome","volume":"4","author":"Hulstein","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1160\/TH08-05-0330","article-title":"Increased Plasma von Willebrand Factor Antigen Levels but Normal von Willebrand Factor Cleaving Protease (ADAHTS13) Activity in Preeclampsia","volume":"101","author":"Molvarec","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/bloodadvances.2017006767","article-title":"Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome","volume":"1","author":"Yoshida","year":"2017","journal-title":"Blood Adv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.thromres.2015.06.022","article-title":"ADAMTS13 Gene Variants and Function in Women with Preeclampsia: A Population-Based Nested Case-Control Study from the HUNT Study","volume":"136","author":"Krogh","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12192-009-0102-4","article-title":"Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia","volume":"14","author":"Molvarec","year":"2009","journal-title":"Cell Stress Chaperon"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Drury-Stewart, D.N., Lannert, K.W., Chung, D., Teramura, G.T., Zimring, J.C., Konkle, B., Gammill, H.S., and Johnsen, J.M. (2014). Complex Changes in von Willebrand Factor-Associated Parameters Are Acquired during Uncomplicated Pregnancy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112935"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/1471-0528.16552","article-title":"Association of placenta-derived extracellular vesicles with pre-eclampsia and associated hypercoagulability: A clinical observational study","volume":"128","author":"Chen","year":"2020","journal-title":"BJOG: Int. J. Obstet. Gynaecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3389\/fimmu.2021.775168","article-title":"COVID-19, Pre-Eclampsia, and Complement System","volume":"12","author":"Agostinis","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3389\/fimmu.2020.01864","article-title":"Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia","volume":"11","author":"Aneman","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/aji.12586","article-title":"Complement component C1q as potential diagnostic but not predictive marker of preeclampsia","volume":"76","author":"Agostinis","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.placenta.2008.07.008","article-title":"The C5b-9 Membrane Attack Complex of Complement Activation Localizes to Villous Trophoblast Injury in vivo and Modulates Human Trophoblast Function in vitro","volume":"29","author":"Rampersad","year":"2008","journal-title":"Placenta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"263109","DOI":"10.1155\/2015\/263109","article-title":"Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia","volume":"2015","author":"Banadakoppa","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e99128","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary Excretion of C5b-9 in Severe Preeclampsia: Tipping the balance of complement activation in pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/AOG.0000000000002980","article-title":"Terminal Complement Activation in Preeclampsia","volume":"132","author":"Burwick","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia Is Characterized by Placental Complement Dysregulation","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2020.03.021","article-title":"Dysregulation of complement system during pregnancy in patients with preeclampsia: A prospective study","volume":"122","author":"He","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2018.04.048","article-title":"Acute Cardiac Effects of Severe Pre-Eclampsia","volume":"72","author":"Vaught","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the treatment of preeclampsia\/HELLP syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fimmu.2020.00548","article-title":"Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS\u2014Case Report","volume":"11","author":"Lokki","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fimmu.2019.00337","article-title":"Complement in Thrombotic Microangiopathies: Unraveling Ariadne\u2019s Thread into the Labyrinth of Complement Therapeutics","volume":"10","author":"Gavriilaki","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjh.14045","article-title":"How we manage thrombotic microangiopathies in pregnancy","volume":"173","author":"Thomas","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2015.03.017","article-title":"Differentiation between Severe HELLP Syndrome and Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura and Other Imitators","volume":"189","author":"Pourrat","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/qjmed\/95.6.343","article-title":"Severe Hepatic Dysfunction in Pregnancy","volume":"95","author":"Rahman","year":"2002","journal-title":"Qjm"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14740\/jh347w","article-title":"HELLP Syndrome, Thrombotic Thrombocytopenic Purpura or Both: Appraising the Complex Association and Proposing a Stepwise Practical Plan for Differential Diagnosis","volume":"7","author":"Ramadan","year":"2018","journal-title":"J. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/1076029608324929","article-title":"Limitations of ADAMTS-13 Activity Level in Diagnosing Thrombotic Thrombocytopenic Purpura in Pregnancy","volume":"15","author":"Ehsanipoor","year":"2008","journal-title":"Clin. Appl. Thromb."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0032-1305799","article-title":"Management of Thrombotic Thrombocytopenic Purpura with Autoantibodies to ADAMTS-13 and Concurrent Preeclampsia in Pregnancy: Multidisciplinary Team Approach","volume":"2","author":"Patrick","year":"2012","journal-title":"Am. J. Perinatol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mousseaux, C., Joly, B.S., Mohamadou, I., Arrestier, R., Hertig, A., and Rafat, C. (2020). Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: A case report. BMC Nephrol., 21.","DOI":"10.1186\/s12882-020-01865-y"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5005\/jp-journals-10006-1791","article-title":"Moschcowitz Syndrome or Thrombotic Thrombocytopenic Purpura and Antiphospholipid Antibody Syndrome as a Rare Cause of Thrombocytopenia in Pregnancy Mimicking Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome in a Patient with Bad Obstetric History: A Diagnostic Dilemma","volume":"12","author":"Bhute","year":"2020","journal-title":"J. South Asian Fed. Obstet. Gynaecol."},{"key":"ref_48","first-page":"1","article-title":"Unfavorable Course in Pregnancy-Associated Thrombotic Thrombocytopenic Purpura Necessitating a Perimortem Cesarean Section: A Case Report","volume":"7","author":"Narbona","year":"2013","journal-title":"J. Med. Case Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: Report from an international working group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:47:17Z","timestamp":1760136437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073851"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073851","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]}}}